Literature DB >> 21182233

Short-segment Barrett's esophagus and cardia intestinal metaplasia: A comparative analysis.

Ying Chang1, Bin Liu, Gui-Sheng Liu, Tao Wang, Jun Gong.   

Abstract

AIM: to investigate the endoscopy and histology of short-segment Barrett's esophagus (SSBE) and cardia intestinal metaplasia (CIM), and their correlation with Helicobacter pylori (H. pylori) gastritis and gastroesophageal reflux disease (GERD).
METHODS: biopsy specimens were taken from 32 SSBE patients and 41 CIM patients with normal appearance of the esophagogastric junction. Eight biopsy specimens from the lower esophagus, cardia, and gastric antrum were stained with hematoxylin/eosin, Alcian blue/periodic acid-Schiff, Alcian blue/high iron diamine and Gimenez dye. Results were graded independently by one pathologist.
RESULTS: the SSBE patients were younger than the CIM patients (P < 0.01). The incidence of dysplasia and incomplete intestinal metaplasia subtype was higher in SSBE patients than in CIM patients (P < 0.01). H. pylori infection was correlated with antral intestinal metaplasia (P < 0.05), but not with reflux symptomatic, endoscopic, or histological markers of GERD in CIM patients. SSBE was correlated with reflux symptomatic and endoscopic esophagitis (P < 0.01), but not with H. pylori infection and antral intestinal metaplasia.
CONCLUSION: dysplasia risk is significantly greater in SSBE patients than in CIM patients. CIM is a manifestation of H. pylori-associated and multifocal atrophic gastritis, whereas SSBE may result from GERD.

Entities:  

Mesh:

Year:  2010        PMID: 21182233      PMCID: PMC3012569          DOI: 10.3748/wjg.v16.i48.6151

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  Barrett's esophagus: the metaplasia-dysplasia-carcinoma sequence: morphological aspects.

Authors:  K Geboes
Journal:  Acta Gastroenterol Belg       Date:  2000 Jan-Mar       Impact factor: 1.316

2.  Gastric cardia inflammation and intestinal metaplasia: associations with reflux esophagitis and Helicobacter pylori.

Authors:  N S Goldstein; R Karim
Journal:  Mod Pathol       Date:  1999-11       Impact factor: 7.842

Review 3.  Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review.

Authors:  Gareth S Dulai; Sushovan Guha; Katherine L Kahn; Jeffrey Gornbein; Wilfred M Weinstein
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

4.  Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.

Authors:  A Ruol; A Parenti; G Zaninotto; S Merigliano; M Costantini; M Cagol; R Alfieri; L Bonavina; A Peracchia; E Ancona
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

5.  Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae.

Authors:  Michael T Barrett; Ka Yee Yeung; Walter L Ruzzo; Li Hsu; Patricia L Blount; Robert Sullivan; Helmut Zarbl; Jeffrey Delrow; Peter S Rabinovitch; Brian J Reid
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

6.  Site distribution of oesophagogastric cancer.

Authors:  J P Byrne; J M Mathers; J M Parry; S E A Attwood; J Bancewicz; C B J Woodman
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

7.  MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.

Authors:  Cameron-M Smith; David I Watson; Michael Z Michael; Damian J Hussey
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

8.  Gene expression profiling in Barrett's esophagus and cardia intestinal metaplasia: a comparative analysis using cDNA microarray.

Authors:  Ying Chang; Jun Gong; Bin Liu; Jun Zhang; Fei Dai
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Barrett's esophagus and its correlation with gastroesophageal reflux in Chinese.

Authors:  Jun Zhang; Xiao-Li Chen; Kang-Min Wang; Xiao-Dan Guo; Ai-Li Zuo; Jun Gong
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

Review 10.  Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease.

Authors:  Kwong Ming Fock; Nick Talley; Richard Hunt; Ronnie Fass; Sanjay Nandurkar; Shiu-Kum Lam; Khean Lee Goh; Jose Sollano
Journal:  J Gastroenterol Hepatol       Date:  2004-04       Impact factor: 4.029

View more
  5 in total

Review 1.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

2.  Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.

Authors:  Prateek Sharma; David A Katzka; Neil Gupta; Jaffer Ajani; Navtej Buttar; Amitabh Chak; Douglas Corley; Hashem El-Serag; Gary W Falk; Rebecca Fitzgerald; John Goldblum; Frank Gress; David H Ilson; John M Inadomi; Ernest J Kuipers; John P Lynch; Frank McKeon; David Metz; Pankaj J Pasricha; Oliver Pech; Richard Peek; Jeffrey H Peters; Alessandro Repici; Stefan Seewald; Nicholas J Shaheen; Rhonda F Souza; Stuart J Spechler; Prashanth Vennalaganti; Kenneth Wang
Journal:  Gastroenterology       Date:  2015-08-19       Impact factor: 22.682

3.  Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments.

Authors:  Cassie L Booth; Kevin S Thompson
Journal:  J Gastrointest Oncol       Date:  2012-09

Review 4.  Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review.

Authors:  Bálint Erőss; Nelli Farkas; Áron Vincze; Benedek Tinusz; László Szapáry; András Garami; Márta Balaskó; Patrícia Sarlós; László Czopf; Hussain Alizadeh; Zoltán Rakonczay; Tamás Habon; Péter Hegyi
Journal:  Helicobacter       Date:  2018-06-25       Impact factor: 5.753

5.  Helicobacter pylori infection is associated with reduced risk of Barrett's esophagus: a meta-analysis and systematic review.

Authors:  Yan-Lin Du; Ru-Qiao Duan; Li-Ping Duan
Journal:  BMC Gastroenterol       Date:  2021-12-07       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.